Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124204862 | 12420486 | 2 | F | 20140817 | 20160719 | 20160531 | 20160729 | EXP | US-BAYER-2014-129608 | BAYER | 80.00 | YR | E | F | Y | 0.00000 | 20160729 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124204862 | 12420486 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | 200 MG, QD | 21923 | 200 | MG | FILM-COATED TABLET | QD | ||||||
| 124204862 | 12420486 | 2 | SS | NEXAVAR | SORAFENIB | 1 | Oral | UNK | 21923 | FILM-COATED TABLET | |||||||||
| 124204862 | 12420486 | 3 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 200 MG, QD/ 200MG DAILY DOSE | 21923 | 200 | MG | FILM-COATED TABLET | QD | ||||||
| 124204862 | 12420486 | 4 | SS | NEXAVAR | SORAFENIB | 1 | 21923 | FILM-COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124204862 | 12420486 | 1 | Malignant connective tissue neoplasm |
| 124204862 | 12420486 | 2 | Soft tissue sarcoma |
| 124204862 | 12420486 | 3 | Tracheal cancer |
| 124204862 | 12420486 | 4 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124204862 | 12420486 | HO |
| 124204862 | 12420486 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124204862 | 12420486 | Anaemia | |
| 124204862 | 12420486 | Blood test abnormal | |
| 124204862 | 12420486 | Drug dose omission | |
| 124204862 | 12420486 | Fatigue | |
| 124204862 | 12420486 | Fluid retention | |
| 124204862 | 12420486 | Haematochezia | |
| 124204862 | 12420486 | Haematocrit decreased | |
| 124204862 | 12420486 | Haemorrhage | |
| 124204862 | 12420486 | Mean cell volume decreased | |
| 124204862 | 12420486 | Off label use | |
| 124204862 | 12420486 | Respiration abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124204862 | 12420486 | 1 | 20130219 | 0 | ||
| 124204862 | 12420486 | 2 | 20130704 | 0 | ||
| 124204862 | 12420486 | 3 | 20130904 | 0 |